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Background: Cervical cancer is the most common cancer in women 
in some Africa and Asia and the third most common cancer in 
women worldwide. Human papillomavirus (HPV) infection is the 
leading cause of cervical lesions and cancers and has a crucial role 
in the progression of cervical cancers. The burden of HPV infection 
itself is very substantial in women worldwide. It was reported that 
approximately 610,000 new patients came out every year worldwide 
in 2012 and the prevalence of HPV infection was 10.4% in 863 
sexually active females aged ranging 20–74 years old in Korea. HPV 
infection could be heritable because the patterns of progression of 
HPV infection are different depending on host’ genetic susceptibility 
and environmental factors. Most infections are cured, but 10–20% of 
women have persistent infections and they could become cervical 
intraepithelial neoplasm (CINs). 30–40% of CINs are progressed to 
invasive cancer of the cervix (ICC).  
 
Objective: The aims of this study were to estimate genetic influences 
and to identify the genetic susceptibility loci with the latest and 
optimal method to analyze dichotomous trait based on the fact that 
there is a significant genetic influence on HPV infection status for 
uterine cervix HPV infection status in Korean Women. 
 
Methods: The 910 study participants aged 25-79 were recruited 
from the females in the Healthy Twin Study. Prevalence of HPV 
infected host and odds ratios of HPV infection status by potential 
risk factors were estimated with a univariate logistic regression 
analysis. To estimate genetic influences, Intra-class correlation (ICC) 
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and SOLAR were used and to identify the genetic susceptibility loci, 
GWAF was used, which is the latest and appropriate method to 
analyze dichotomous trait. 
 
Results: Among epidemiological factors, only oral contraceptive use 
was significantly associated with HPV infection status. The ICC 
coefficient of monozygotic (MZ) twin pairs were higher than mother 
and daughter pairs and dizygotic (DZ) twin and sibling pairs. Genetic 
influences also exist moderately (h2=0.34) in AE model of HPV 
infection status. In addition, Genetic susceptibility loci of HPV 
infection status were rs13386094, rs13393102, rs10187756, 
rs13006868, rs28479291, rs12694475, and rs10165222 in additive 
model and rs7595290 in general model. They were significantly 
associated with the phenotype with p-value, 5.4E-7 and 8.0E-8 
respectively. After analysis, several visualization methods were 
used to explain the results. 
 
Discussion: Genetic influences of HPV infection status are not that 
high but significantly heritable. Among the genes from the results in 
additive model, BROX, CNTN5, GRM8, HMCN1, NEB, PDE4B, PRKAG2, 
PTPRJ, RHEB, STRC, VNN1, ZBTB7C, ZC3H15, ZNF680, DPP6, RAD51B, 
and WWOX were statistically associated with diseases such as 
endometrial cancer and uterine tumor and function of binding of 
ovarian cancer cell lines (Table 5). In addition, ADAM12, CNTN4, 
DPP6, GRM8, LRP1B, OBSCN, PDE4D, PLEKHH2, PRKAG2, PTPRJ, RHEB, 
STRC, STXBP6, VNN1, ZBTB7C, ZC3H15, ZNF680, PDE4D, WWOX, 
LEPR, and DTD1 were significantly related with the diseases such as 
endometrial cancer, uterine tumor and the functions in G1/S phase 
transition of cervical cancer cell lines, early or advanced stage 
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I. Introduction  
 
 
1. HPV is the key Risk factor of cervical cancer 
 
Cervical cancer is the most common cancer in women in some Africa 
and Asia and the third most common cancer worldwide in women (1, 
2). Approximated 529,000 new patients were calculated in 2008. It 
has been very well known that Human papillomavirus (HPV) infection 
is the leading cause of cervical lesions and cancers and has a crucial 
role in the progression of cervical cancers(3-6). Harald zur Hausen, 
‘the Father of HPV Virology’, first found a relationship between HPV 
infection and cervical tumor and won the 2008 Nobel Prize(7).  
HPV is absolutely species-specific and a small and circular double-
stranded DNA virus. HPV infection in genitalia is very common 
worldwide, usually transmitted by sexual intercourse. Global burden 
of HPV infection is substantial. Approximately 610,000 new patients 
came out every year worldwide in 2012 (8). It has been reported that 
overall prevalence of HPV infection is 10.4% in 863 sexually active 




2. HPV infection has genetic influence. 
 
It has been established that cervical cancer are heritable and where 
genetic susceptibility loci for cervical cancer are. The women who 
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have a mother and/ or sister(s) with the history of cervical cancer 
had significantly higher risk than those who with the second or more 
relatives (10-14). In addition, several studies on heritability of 
cervical cancer suggested that having a first degree relative with 
cervical cancer increases an individual’s risk by one to two fold (15).   
HPV infection also could be heritable. However, genetic 
susceptibility loci of HPV infection were not clearly demonstrated. 
The patterns of progression of HPV infection are different depending 
on host’ genetic susceptibility and environmental factors. Most 
infections are cured, but 10–20% of women have persistent 
infections. It is clear that grade 2/3 cervical intraepithelial 
neoplasms (CINs), which are ranging from low-grade CIN1 to high-
grade CIN3, could be progressed to invasive cancer of the cervix 
(ICC). 30–40% of CINs are progressed to ICC (3,16). Only parts of 
lesions infected by high-risk HPV do progress to cervical cancers (17, 
18). Many observations suggested that host’s genetic predisposition 
has a role in HPV-induced malignant progression as a Non-HPV risk 
factor (6). Variety of studies have found that mothers in HPV risk 
group who have a history of genital warts, abnormal Pap smears, or 
cervical dysplasia have higher risk of HPV vertical transmission to 
their new born infants (19). However, the genetic influence of HPV 
infection susceptibility has yet to be cleared. 
Sophia S. Wang et al. scrutinized which SNPs were associated with 
HPV persistence and progression to CIN3 and cervical cancer based 
on their hypothesis that host genetic variance might differently 
affect the risk of progression from infection with oncogenic HPV and 
some SNPs was significantly associated with the two progresses 
including SNPS residing in genes, RSP19 and PRDX3 (20, 21). The 
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research team replicated the result in Nigerian women and had same 
results (22). B.S. Chagas et al. found SNP rs1800896 in interleukin-
10 promoter region and a significantly greater susceptibility to 
progressive cervical lesions in HPV infected women who use oral 
contraceptives (18). However, a study in Japan performed GWAS to 
identify SNPs related with susceptibility to persistent infection in 




3. Risk factor of HPV 
 
It have been studied about the risk factors for HPV infection in 
previous researches. Above 65 year aged subjects were the highest 
group of HPV infection (23). Education level, Marital status, Tobacco 
use, and sexual behavior such as age at sexual debut (24-27) , the 
possibility of extramarital affairs, history of sexually transmitted 
disease, vaginal douching and oral contraceptive use were 
significantly associated with HPV infection status (23, 25-27). A 
study among Korean women demonstrated Systemic Lupus 






It already has been identified that the HPV infection status depends 
on an individual’s genetic variation. In this study, the aims were to 
estimate genetic influences and to identify the genetic susceptibility 
loci with the latest and optimal method to analyze dichotomous trait 
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based on the fact that there is a significant genetic influences on 


































1. Study population 
 
The study participants were recruited from the Healthy Twin Study. 
They were aged 25-79 and all females. The recruitment in Healthy 
Twin Study stared out from the 3 hospitals; Samsung Medical Center, 
Seoul (n=617), Busan Paik Hospital, Busan (n=225), and Dankook 
University Hospital, Cheonan (n=68) from 2005 and is still followed 
up. The women who haven’t had history of cervical cancer before 
taking the Papanicolaou (Pap) smear test at that time and their 
cervico-vaginal smear samples were collected and completed 
questionnaires. The information from the questionnaires covering 
demographics, family history, behavioral factors related with 
lifestyle (oral contraceptive pill use, smoking, and alcohol 
consumption), social-economic status (educational level, marital 
status) and clinical information (blood, urine, cervico-vaginal smear 







The Genomic DNA of 910 subjects was extracted from blood 
samples at their medical checkup examination, and it was 
genotyped by Affymetrix Genome-Wide Human SNP Array 6.0 
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(Affymetrix, CA USA) and Illumina HumanCore-12 BeadChip Kit 
(Illumina, USA). WTCCC was used to check quality control (QC). 
Markers that did not meet criteria were not included in final Markers. 
The criteria was that duplicated, Mendelian inconsistency in > 3 
families, Non-Mendelian inconsistency in > 3 families, Minor Allele 
Frequency(MAF) < 0.01, Hardy-Weinberg Equilibrium(HWE) < 0.001, 
Genotype missing rate > 0.05 (30). For phasing, SHAPEIT2 was used. 
Then, IMPUTE2 was used to perform imputation and the genotype 
that imputation quality score was over 0.9 only remained. Reference 
haplotype was 1000 Genome haplotypes phase I integrated variant 
set release GRCh37/hg19 in Asian population. 
As for HPV genotyping, the 910 subjects’ HPV samples were 
genotyped. A liquid-based preparation method was used by 
following standard procedures (ThinPrep® , Hologic, USA and 
SurePath™, BD Diagnostics-TriPath, USA). For extracting genomic 
DNA, The Chemagic viral DNA/RNA kit (Chemagen, Germany) was 
used. After being conducted by PCR, the sequences of HPV were 
identified by NCBI BLAST program, and genotyping HPV was 
completed. If HPV infection was detected by at least one of two 
primer sets, it would considered positive, and was not done by 
either primer sets, negative. In the result, there were 12 HPV high-
risk genotype groups (16, 18, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 
66), 5 low-risk groups (32, 42, 43, 54 and 70) and seven risk-
undetermined HPV genotype groups (30, 67, 74, 81, 84, 90 and 
102). Specific subtypes of HPV have different effects (31, 32). Like 
many other studies, 16 and 18 were the most common and strongly 
associated with the risk of cervical cancer (23, 31-33). Among 910, 




3. Statistical analysis 
 
The design of this study is a cross-sectional study, consisting of 
case and control group. In univariate logistic regression analysis, the 
generalized estimating equation (GEE) model was applied, in which 
genetic correlations between families were treated as random effects. 
Odds ratios with 95% confidence intervals were estimated for each 




4. Heritability analysis 
 
To estimate genetic influence of HPV infection study, the coefficients 
of Intra-class correlation (ICC) and heritability estimates were 
calculated. HPV infection status with low and high risk group in case 
and with only high risk group were compared in this analysis.  
The ICC is a measure of the degree of resemblance between two 
elements of a particular cluster. It was calculated between the pairs 
of Monozygotic (MZ) twin, mother and daughter and Dizygotic (DZ) 
twin, sibling pairs by using the software, SAS v. 9.4. (SAS Institute 
Inc., USA). The more similarity of HPV infection status between any 
pairs, the higher the coefficient of ICC 
Estimation of Heritability was conducted by a software package, 
SOLAR that stands for Sequential Oligogenic Linkage Analysis 
Routines using a genetic variance-components model. Heritability 
means the proportion of the phenotypic variance (VP) in a trait that is 
attributable to the genetic variation (VG) between individuals. 
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Depending on definition of genetic variation, heritability could be 
divided as Broad-sense heritability and narrow-sense heritability. 
Broad-sense heritability captures the proportion of phenotypic 
variation due to genetic values that may include effects due to 
dominance and epistasis. 
 
H2 = VG/VP 
 
On the other hand, in narrow-sense (additive genetic) heritability, 
h2 captures only that proportion of genetic variation that is due to 
additive genetic values (VA). 
 
h2 = VA/VP 
 
Shared environmental (household) effects, C2 captures that 
proportion of variance due to shared environmental influences. 
 
C2 = Vc/VP 
 
In this study, AE and ACE models were Akaike information criterion  
 
(AIC) =2k-2ln (L) 
k: the number of estimated parameters 
L: maximized likelihood 
 
Thus, the AIC value is defined as the log-likelihood penalized by the 






5. GWAS analysis 
 
In the previous study, GWAS of HPV was analyzed by plink and FBAT 
a few years ago. Using plink and FBAT, However, was not a good 
method to analyze dichotomous data. It is impossible to use total 
number of samples. Because only 424 samples were used among 
the total samples, power decreased. In addition, there was no any 
evidence of genetic influence between the pairs. For identifying the 
genetic susceptibility loci for uterine cervix HPV infection status, 
GWAF were used because those method is currently the optimal 
ways to analyze dichotomous trait correctly. In addition, they made 
it possible to use total sample size.  
GWAF stands for Genome-Wide Association analyses with Family 
and is also an R package designed mainly for analyzing GWAF. It 
carries out association tests between single nucleotide 
polymorphisms (SNPs) and a dichotomous trait with specified 
genetic model. Logistic regressions is used in this package to 
analyze dichotomous traits within pedigree correlation via 
generalized estimating equations. In addition, a general (7, 34-35).  
Two models were used in GWAF analysis which are additive model 
and general model. In additive model, beta coefficients were 
calculated per 1 copy increase of coded allele, which had been 
coded as 0, 1 and 2. In general model, beta coefficient for genotype 
1 vs. 0, 2 vs. 0 and 2 vs. 1 were estimated respectively. When allele 
counts are zero or low, general model may be replaced by dominant 
model in analysis. Dominant model have beta coefficient for 
genotype 1 and 2 combined vs. genotype 0. The Chi-square statistic 
of general model is tested whether at least one of the beta10 and 
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6. Visualization methods 
 
After GWAS analysis, several methods were used to visualize briefly 
and interpret the result of GWAS analysis. Quantile-Quantile(Q-Q) 
plot, Manhattan plots, Regional plots and Linkage disequilibrium 
plot were drawn. These methods are commonly used after GWAS 
analysis.  
The QQ plot was drawn by using R package, ‘qqman’. The Q-Q plot 
make it possible to check whether a result of GWAS follows the 
expected distribution or not. In other words, it displays the observed 
association of all SNPs with P-value obtained by GWAS results on the 
y-axis versus the expected distribution of p-values on the x-axis 
under the null hypothesis that there is no association. If a result 
follows expected uniform distribution exactly, it means SNPs are not 
associated with phenotype. However, the result with strongly 
associated SNPs will show deviation at the upper-right end of the 
plot on the diagonal. QQ plot could be used to find systematic bias. 
Deviation from the diagonal may indicate that data has systematic 
bias such as population stratification or strong correlation (36).  
The Haploview is web-based program and used to analyze HapMap 
data, choose tag-SNPs and test for association. The Manhattan plots 
drawn by the HaploView display p-value (–log10) of SNPs on y-axis 
by chromosome numbers on x-axis. Genetic regions with highly 
associated SNPs in linkage disequilibrium shows peaks along the 
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plot (37).  
Linkage disequilibrium (LD) plot is also generated by the Haploview. 
The LD plot implies the high possibility that statistically associated 
SNPs are in the same LD block formed by historical recombination 
hot spots. Red represents ‘strong LD between markers and blue 
does ‘no LD’ (37). 
The Regional association plot is drawn to zoom any interesting 
region of GWAS results by web-based grogram ‘LocusZoom’. 
Hg19/1000 Genomes 2010 HapMap Asian population were used in 
the study (38).  
Ingenuity Pathway Analysis (IPA) is a web-based software application 
to identify the pathway, molecular mechanisms, and gene functions. 
The IPA was used to study the gene products and their diseases and 




















1. Statistical result 
 
Table 1. Shows the prevalence of HPV infected host and estimated 
odds ratios of HPV infection status by potential risk factors such as 
age, educational level, marital status, oral contraceptive use, 
smoking, and alcohol intake with a univariate logistic regression 
analysis via GEE. However, only oral contraceptive use was 
significantly associated with HPV infection status and the other 
factors were not in this study. Therefore, oral contraceptive use and 



















Table 1. Prevalence of HPV infected host (n=74) and odds ratios estimated  of HPV infection 




OR (95% CI) P 
Age(years) ≤34 9 (1.0) 1 
 
 
35-44 26 (2.9) 1.24(0.45-2.03) 0.5873 
 
45-54 21 (2.3) 1.24(0.43-2.06) 0.5984 
 
55-64 10 (1.1) 0.68(-0.25-1.61) 0.4168 
 
≥65 8 (0.9) 1.40() 0.5067 
Education level <Elementary school 11 (1.2) 1 
 
 
High school 42 (4.6) 2.16(1.48-2.85) 0.027 
 
> College 21 (2.3) 1.76(1.00-2.51) 0.143 
Marital status Never 5 (0.6) 1 
 
 








Never 51 (5.6) 1 
 
Ever used 18 (2.0) 1.68(1.12-2.25) 0.0715 
Current used 5 (0.6) 13.47(12.20-14.74) 0.0001 
Smoking Never smoker 68 (7.5) 1 
 
 
Ever smoker 4 (0.4) 1.93(0.84-3.02) 0.2369 
 
Never smoker 2 (0.2) 0.38(-1.05-1.81) 0.1886 
Alcohol intake Never smoker 28 (3.1) 1 
 
 
Ever smoker 7 (0.9) 1.30(0.43-2.16) 0.5547 
 
Never smoker 39 (4.3) 1.37(0.87-1.88) 0.2175 











2. Heritability analysis 
 
Table 2 is the result of ICC and heritability estimation of HPV 
infection status and high risk HPV infection. While HPV itself isn't 
heritable, HPV infection status could be heritable. Thus, I was 
interested in how heritable HPV infection susceptibility is. Genetic 
influence of HPV was calculated by analyzing intra class correlation 
and heritability of HPV infection status.  
ICC coefficients are the Correlation Coefficients between pairs in this 
study, pairs mean MZ twin pairs, mother and daughter pairs and DZ 
twin and sibling pairs. In this study, age and oral conceptive use 
were adjusted. In the result of ICC calculation, you can see 
coefficients increase as genetic similarity increae between pairs. For 
high risk HPV infection, the result is also similar to HPV infection 
status but slightly higher than HPV infection status. Overall, The ICC 
of MZ twin pairs were higher than mother and daughter pairs and 
DZ twin and sibling pairs.  
 In heritability estimates, A, E and C mean additive genetic factor, 
shared common environmental factor and shared environmental 
factor respectively. In addition, H2 and c2 stand for genetic 
component and shared common environmental component between 
pairs respectively. There were two kinds of model; AE and ACE 
model. The shared environmental factor implied household effect in 
ACE model. For HPV infection status, household effect was not 
significant. As for high risk HPV infection status, both model were 
not significant.  







Table 2. Intra-class correlations and heritability estimates of HPV and high risk group HPV infection status 
(n=910).  
  













































 CI, confidence interval; MZ, monozygotic; M-D,  mother and daughter ; DZ, dizygotic; SE, standard error;  
H_HPV, high risk group HPV infection; HPV, human papillomavirus. 








3. GWAS result 
 
Based on the result that HPV infection status are heritable, genome-
wide association study was conducted to find the genetic 
susceptibility loci. Table 3, 4 describe the GWAF results of HPV 
infection status with top SNPs associated with HPV infection status 
and base pairs, chromosome number and p-value. GWAF identified 
rs13386094, rs13393102, rs10187756, rs13006868, rs28479291, 
rs12694475, and rs10165222 in additive model (Table 3) and 
rs7595290 in general model as the most significant SNPs (Table 4) 












Table 3. List of significant SNPs associated with HPV infection status in additive model. 
SNP BP BETA SE A1 A2 MAF REMARK PVAL CHR GENES 








rs10165222 220573146 1.60 0.32 T C 0.035  5.40E-07 2 
rs13393102 220551326 1.60 0.32 A G 0.035  5.40E-07 2 
rs10187756 220555202 1.60 0.32 T A 0.035  5.40E-07 2 
rs13006868 220558099 1.60 0.32 A G 0.035  5.40E-07 2 
rs28479291 220564943 1.60 0.32 C G 0.035  5.40E-07 2 
rs12694475 220565558 1.60 0.32 A G 0.035  5.40E-07 2 
rs13395224 220591842 1.60 0.32 A G 0.035  5.55E-07 2 
rs12694477 220592325 1.60 0.32 A G 0.035  5.55E-07 2 
rs34364745 220549123 1.60 0.32 C A 0.035  5.67E-07 2 
rs7564121 220550509 1.60 0.32 C A 0.035  5.67E-07 2 
rs7595290 220561751 1.65 0.33 A G 0.035 logistic reg  7.67E-07 2 
rs3784119 68875060 0.88 0.18 C G 0.436 
 
1.35E-06 14 RAD51B 
rs12617025 44404068 0.99 0.22 A T 0.167 
 
6.53E-06 2 PPM1B 
rs60374651 11489955 0.88 0.20 A T 0.227 
 
7.26E-06 16 LOC388210 
rs6945103 151254576 1.92 0.44 C T 0.016 
 
1.14E-05 7 PRKAG2 
rs35587783 78805928 0.83 0.19 A G 0.242 
 
1.23E-05 16 WWOX 
rs267366 174908483 0.88 0.20 A G 0.169 
 
1.63E-05 5 SFXN1 
rs7240386 45578566 0.82 0.19 T C 0.277 
 
1.69E-05 18 ZBTB7C 
rs12401430 210031064 0.98 0.23 G A 0.129 
 
1.95E-05 1 DIEXF 
rs75777472 66522801 1.27 0.30 T C 0.086 
 
2.24E-05 15 MEGF11 
rs7235794 54807183 0.78 0.18 A G 0.232 
 
2.61E-05 18 LOC102724717 
rs71477912 48187839 1.09 0.26 C A 0.052 
 
2.63E-05 11 PTPRJ 
rs2272996 133015271 0.86 0.21 C T 0.426 
 
2.67E-05 6 VNN1 
rs78249280 26975645 2.49 0.59 G A 0.010 logistic reg  2.76E-05 9 IFT74 
rs62544411 26885773 2.36 0.57 G C 0.012 logistic reg  3.45E-05 9 CAAP1 
rs16910873 26904699 2.36 0.57 T G 0.012 logistic reg  3.45E-05 9 PLAA 
rs2942150 204436520 0.80 0.19 G A 0.174 
 
3.73E-05 1 PIK3C2B 
rs77498752 64008144 1.58 0.39 G C 0.025  4.38E-05 7 ZNF680 
rs150815613 64061785 1.58 0.39 C T 0.026  4.50E-05 7 LOC100128885 
18 
 
rs2515375 99400574 -0.70 0.17 T C 0.394 
 
4.90E-05 11 CNTN5 
rs118047174 152536057 1.12 0.28 C T 0.069 
 
5.10E-05 2 NEB 
rs1713965 57921536 1.36 0.34 T C 0.030  5.15E-05 4 IGFBP7 
rs10117455 126692599 0.93 0.23 G A 0.102  5.22E-05 9 DENND1A 
rs73256510 21676324 1.23 0.31 A T 0.053 logistic reg 5.41E-05 4 KCNIP4 
rs35093122 27288449 -0.75 0.19 G C 0.445 
 
5.63E-05 10 ANKRD26 
rs2291835 222833538 0.95 0.24 T C 0.149 
 
5.84E-05 1 MIA3 
rs77174914 90094423 1.25 0.31 C T 0.047 logistic reg 6.04E-05 11 DISC1FP1 
rs17164985 762285 0.92 0.23 T C 0.133 
 
6.15E-05 4 PCGF3 
rs8089891 6022584 0.89 0.22 G A 0.116 
 
6.16E-05 18 L3MBTL4 
rs147814821 154385994 1.41 0.35 A T 0.024  6.65E-05 7 DPP6 
rs10198525 187355805 1.69 0.42 A G 0.021  6.67E-05 2 ZC3H15 
rs12686284 6919218 0.97 0.24 C T 0.141  6.76E-05 9 KDM4C 
rs141365434 43912682 1.47 0.37 G C 0.027  7.51E-05 15 STRC 
rs150360531 151215611 1.79 0.45 A G 0.014  7.56E-05 7 RHEB 
rs112399429 222899826 0.89 0.23 A G 0.154  7.87E-05 1 BROX 
rs73207751 787947 0.91 0.23 A G 0.137  8.26E-05 4 CPLX1 
rs1322374 186114325 -0.78 0.20 G C 0.424  8.40E-05 1 HMCN1 
rs58090135 44131706 1.47 0.37 G A 0.026  8.48E-05 15 WDR76 
rs10133149 59449594 0.77 0.20 T C 0.226  8.57E-05 14 LINC01500 
rs140215756 44065643 1.47 0.37 G C 0.026  8.58E-05 15 ELL3 
rs7777222 126889537 1.54 0.39 T C 0.020  8.59E-05 7 GRM8 
rs1518404 58268180 1.42 0.36 G C 0.038  9.01E-05 2 VRK2 
rs7986923 102854467 -0.86 0.22 A G 0.327  9.39E-05 13 FGF14 
rs1529989 85143822 0.64 0.16 C T 0.370  9.44E-05 8 RALYL 
rs17011714 222922168 0.88 0.23 T C 0.154 
 
9.46E-05 1 FAM177B 
rs9326069 66257416 0.94 0.24 G T 0.108 
 
9.51E-05 1 PDE4B 
rs4656441 165244152 0.88 0.23 C T 0.164 
 
9.79E-05 1 LMX1A 





Table 4. List of significant SNPs associated with HPV infection status in general model. 
SNP BP BETA10 BETA20 BETA21 SE10 SE20 SE21 A1 A2 MAF REMARK PVAL CHR GENE 

















C G 0.035  5.40E-07 2 




T C 0.035  5.40E-07 2 




A G 0.035  5.40E-07 2 




A G 0.035  5.40E-07 2 




A G 0.035  5.40E-07 2 




A G 0.035  5.40E-07 2 




T A 0.035  5.40E-07 2 




A G 0.035  5.55E-07 2 




A G 0.035  5.55E-07 2 




C A 0.035  5.67E-07 2 




C A 0.035  5.67E-07 2 
rs10976053 7126175 -0.17 1.37 1.53 0.34 0.35 0.33 T G 0.420  3.51E-06 9 KDM4C 
rs7197903 78614508 1.35 0.13 -1.22 0.29 0.74 0.70 T C 0.227  7.80E-06 16 WWOX 




C T 0.016  1.14E-05 7 PRKAG2 
rs139897525 78237846 -0.13 1.49 1.62 0.30 0.35 0.38 G C 0.254 
 
1.79E-05 5 ARSB 
rs6045573 18713002 -0.55 1.67 2.22 0.39 0.44 0.49 G A 0.170  2.34E-05 20 DTD1 
rs9911268 29094253 0.61 2.38 1.77 0.30 0.55 0.60 T C 0.133  2.38E-05 17 SUZ12P1 
rs1036837 67150897 0.11 2.07 1.96 0.32 0.46 0.48 T A 0.205  2.38E-05 18 DOK6 
rs3798800 133012322 0.58 1.64 1.06 0.39 0.39 0.31 T G 0.417  2.44E-05 6 VNN1 
rs79146542 228523171 -0.54 2.01 2.55 0.39 0.48 0.57 C A 0.141 
 
2.46E-05 1 OBSCN 




T A 0.053 
 
2.80E-05 4 KCNIP4 
rs4476244 45572794 0.42 1.95 1.53 0.32 0.43 0.44 T C 0.155 
 
3.02E-05 18 ZBTB7C 
20 
 
rs7920391 127769667 -0.61 1.14 1.74 0.32 0.36 0.39 G A 0.331 
 
3.54E-05 10 ADAM12 
rs4561818 2386690 -0.19 2.01 2.20 0.33 0.47 0.52 G A 0.145  3.81E-05 3 CNTN4 




G A 0.028  3.89E-05 4 IGFBP7 




A G 0.025  4.38E-05 7 ZNF680 
rs7108003 124966473 0.09 1.68 1.59 0.32 0.39 0.43 C T 0.176  4.49E-05 11 TMEM218 




T C 0.026  4.50E-05 7 LOC100128885 
rs4235478 59521789 0.02 2.61 2.59 0.38 0.59 0.66 C T 0.101  4.56E-05 5 PDE4D 




T G 0.090  4.57E-05 15 MEGF11 




C T 0.052  4.65E-05 15 CA12 
rs13079108 9980469 -0.62 1.84 2.46 0.33 0.50 0.55 A G 0.210  5.02E-05 3 CRELD1 
rs7980896 94289647 0.24 1.36 1.12 0.38 0.37 0.30 A G 0.411  5.15E-05 12 CRADD 
rs10509708 98069164 -0.01 2.13 2.14 0.38 0.49 0.56 T C 0.090  5.35E-05 10 DNTT 
rs72622319 111285519 0.47 2.56 2.09 0.30 0.58 0.59 G A 0.159  5.38E-05 3 CD96 
rs12035604 66056052 -0.95 1.30 2.25 0.36 0.46 0.51 T A 0.201  5.59E-05 1 LEPR 




T C 0.008  6.05E-05 2 LRP1B 
rs10174938 43873144 0.24 1.49 1.24 0.31 0.36 0.35 T C 0.343  6.08E-05 2 PLEKHH2 
rs2942150 204436520 1.20 0.99 -0.22 0.27 0.58 0.57 C A 0.174  6.41E-05 1 PIK3C2B 
rs11626436 25511680 0.28 2.06 1.78 0.31 0.47 0.49 G C 0.182  6.51E-05 14 STXBP6 




A G 0.024  6.65E-05 7 DPP6 




G A 0.021  6.67E-05 2 ZC3H15 
rs10490924 124214448 -1.35 0.01 1.35 0.33 0.32 0.36 T C 0.428  7.11E-05 10 ARMS2 




T G 0.050  7.21E-05 11 TMEM135 




A G 0.027  7.51E-05 15 STRC 




C T 0.014  7.56E-05 7 RHEB 




T A 0.040  7.96E-05 11 PTPRJ 
21 
 




T C 0.026  8.48E-05 15 WDR76 




G A 0.026  8.58E-05 15 ELL3 




T C 0.020  8.59E-05 7 GRM8 




G A 0.038  9.01E-05 2 VRK2 




A T 0.010  9.11E-05 9 IFT74 
rs167556 77035346 -0.84 1.22 2.07 0.37 0.42 0.48 C T 0.208 
 
9.39E-05 1 ST6GALNAC3 
















After GWAS analysis, several visualization methods was used to 
explain the results. 
Figure 1 presents the QQ plot of GWAS result of HPV infection 
status in additive model. It displays the observed association P-
value of all SNPs obtained by GWAS results on the y-axis versus 
the expected distribution on the x-axis. The upper-right points 
are deviated from the diagonal, which means there are the several 
significant associated SNPs in the result. Figure 2 also present the 
similar result in general model.  
Figure 3, 4 shows the Manhattan plots for HPV infection status in 
additive model and general model respectively. The spot is above 
the red line (5.0E-07) in general model. The number of 
chromosome 2 have the highest peak in both models.   
Figure 5, 6 display the regional plots that zoom in narrow regions 
for rs13386094 in additive model and in chromosome 2 and 
rs7595290 in general model both in chromosome 2.  The purple 
diamond indicate the strongest risk SNPs and the other dots are 
located within LD of r2 from 0 to 1.  
Figure 7, 8 visualize the LD mapping plots with the 12 significant 
SNP with p-value below (5.0E-07). Red diamond boxes mean the 
relationship between the two loci among 12 SNPs with D prime. D 
prime of all pairs were 1, which means the 12 SNPs are located in 
the same LD block in both models. The yellow star in figure 8 
show the locations of rs13386094 of the general model that was 




Figure 1. The QQ plot of GWAS result of HPV infection status in 
additive model. 
 





Figure 3. The Manhattan plot for HPV infection status in additive 
model. 





Figure 5. The Regional plot for rs13386094 in chromosome 2 in 
additive model.  
 
Figure 6. The Regional plot for rs7595290 in chromosome 2 in 




Figure 7. The LD plot in additive model (D’=1) 
 
 





The author’s finding suggests that genetic influences of HPV 
infection status in Korean women were not that high but 
significantly heritable. In further analysis, Genetic susceptibility 
locus of HPV infection status were rs13393102, rs10187756, 
rs13006868, rs28479291, rs12694475, rs10165222 and 
rs13386094 in additive model and rs7595290 in general model as 
the most significant SNPs. They were significantly associated with 
the phenotype, 5.40-7 and 7.98-8, but they had quite low MAF values 
and were not included in or closed with meaningful gene regions. 
Because there is a possibility of false positive in these 12 top SNP, 
this trait needs to be replicated by other studies. On the other hand, 
several SNPs were closed to known genes within range of p-value 
from 1.0-6 below 1.0-5.  
IPA was used to make these gene lists and their functions which has 
been disclosed by several studies. Among the genes from the GWAF 
results in additive model, BROX, CNTN5, GRM8, HMCN1, NEB, PDE4B, 
PRKAG2, PTPRJ, RHEB, STRC, VNN1, ZBTB7C, ZC3H15, ZNF680, DPP6, 
RAD51, and WWOX were statistically associated with diseases such 
as endometrial cancer and uterine tumor and function in binding of 
ovarian cancer cell lines in Table 5. In addition, ADAM12, CNTN4, 
DPP6, GRM8, LRP1B, OBSCN, PDE4D, PLEKHH2, PRKAG2, PTPRJ, RHEB, 
STRC, STXBP6, VNN1, ZBTB7C, ZC3H15, ZNF680, WWOX, LEPR and 
DTD1 might be related with the diseases such as endometrial cancer 
and uterine tumor and the functions in G1/S phase transition of 
cervical cancer cell lines, early or advanced stage endometriosis, 
binding of ovarian cancer cell lines and apoptosis of endometrial 
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cancer cell lines in Table 6. 
There is only one study about HPV infection, which was reported on 
the website of National Human Genome Research Institute 
(http://www.genome.gov/gwastudies). However, it is about head 
and neck HPV infection not uterine cervix. The Strongest SNP-Risk 
Allele and its reported gene found in a previous study are in Table 7. 
Table 6 also shows that ADAM12, CNTN4, DPP6, IGFBP7, KDM4C, 
LRP1B, MEGF11, OBSCN, PIK3C2B, STRC, VRK2S which have been 
reported that they are associated with head and neck cancers. HPV 
infection is related with 4 % of entire of cancers. Several studies have 
indicated that infection with specific HPV types is a contributing 
factor to different types of anogenital cancer, including cervical, anal, 
penile, and even head, neck and oropharyngeal cancers (3, 40-42). 
HPV is also known as a main factor of lung, cancer. Iver Petersen 
et.al concluded that HPV infection is the second contributing risk 
factor of lung cancer (43).  
Table 9 shows the list of measures of LD between two SNPs among 
the top 12 SNPs. ‘L1 and L2’ are the two SNP pairs and D' is the 
measurement of D prime between the two loci. ‘LOD’ is the log of 
the likelihood odds ratio, a measure of confidence in the value of D'. 
‘r2’ is the correlation coefficient between the two loci. ‘Dist’ is the 
distance (bp) between the loci. 
A study indicated that the number of High risk HPV infected women 
was higher Among HIV positive women than HIV negative. Thus, it 
suggested that it is helpful for young HIV infected women to make 
sure to take HPV examination for cervical cancer screening (44). 
Once young women in Korea start having sexual intercourse HPV 
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prevalence increase faster than those in the United States and in 
northern Europe even though they tend to start late (9). It was 
examined about the relationship between Internet search activity for 
HPV and HPV vaccine uptake. It is significantly correlated between 
vaccine search volume and HPV coverage thus, the search term 
vaccine independently predicted HPV vaccination coverage to 
support vaccine decision making.(45) Despite of heavy global 
burden of HPV infection, application of vaccines could reduce 
significantly the burden of cervical cancer worldwide(6).  
There is a limitation in this study. Ideal study design for identifying 
genetic effect of HPV infection on cervical uterine would be done by 
considering progression of HPV infection level instead of status. 
However, it must be attributable if further analysis is conducted 
based on the result of this cross-sectional study concerning on HPV 
infection. 
To conclude, Heritability, GWAS analysis were performed to estimate 
genetic influences and to identify the genetic susceptibility loci for 
uterine cervix HPV infection status in Korean Women. This study 
identified genetic variants, genes and functions associated with HPV 
infection status. In addition, it is very meaningful to use the latest 
and optimal method to analyze dichotomous trait. If this finding is 
replicated for further analysis with another cohort, it will be more 
clear the relationship between this trait and the genetic variants 







Table 5. List of diseases and functions associated with the genes in additive model. 
Categories 






























Signaling and Interaction 
binding of ovarian 



















Table 6. List of diseases and functions associated with the genes in general model. 
Categories 
































G1/S phase transition of 
cervical cancer cell lines 1.53E-02 
DTD1 
Cell Death and 
Survival 
 
apoptosis of endometrial 
cancer cell lines 1.75E-02 
PDE4D 
apoptosis of ovarian cancer 





binding of ovarian cancer 










early stage endometriosis 8.79E-03 
LEPR 
Head and neck 










Table 7. List of diseases and functions associated with the closest genes near the top associated SNPs 
Categories 
Diseases or Functions 
Annotation 
p-Value Genes 
Cell Death and 
Survival 
cell viability of cervical 
cancer cell lines 1.30E-02 PTPRN 
apoptosis of granulosa 
cells 8.46E-03 INHA 
Reproductive 
System Disease 
premature ovarian failure 1.84E-02 INHA 
polycystic ovary syndrome 3.79E-02 INHA 
 
Table 8. List of SNP and genes found in previous study. 
First 













study of HPV 







Table 9. List of measures of LD between two SNP pairs among the top 12 SNPs. 
L1 L2 D' LOD r^2 Dist 
rs34364745 rs7564121 1 (0.98-1) 148.02 1 1386 
rs34364745 rs13393102 
1 (0.98-1) 
148.02 1 2203 
rs34364745 rs10187756 
1 (0.98-1) 
148.02 1 6079 
rs34364745 rs13006868 
1 (0.98-1) 
148.02 1 8976 
rs34364745 rs7595290 1 (0.97-1) 144.17 0.977 12628 
rs34364745 rs28479291 
1 (0.98-1) 
148.02 1 15820 
rs34364745 rs12694475 
1 (0.98-1) 
148.02 1 16435 
rs34364745 rs10165222 
1 (0.98-1) 
148.02 1 24023 
rs34364745 rs13386094 
1 (0.98-1) 
148.02 1 24468 
rs34364745 rs13395224 
1 (0.98-1) 
147.99 1 42719 
rs34364745 rs12694477 
1 (0.98-1) 
147.99 1 43202 
rs7564121 rs13393102 
1 (0.98-1) 
148.02 1 817 
rs7564121 rs10187756 
1 (0.98-1) 





148.02 1 7590 
rs7564121 rs7595290 1 (0.97-1) 144.17 0.977 11242 
rs7564121 rs28479291 
1 (0.98-1) 
148.02 1 14434 
rs7564121 rs12694475 
1 (0.98-1) 
148.02 1 15049 
rs7564121 rs10165222 
1 (0.98-1) 
148.02 1 22637 
rs7564121 rs13386094 
1 (0.98-1) 
148.02 1 23082 
rs7564121 rs13395224 
1 (0.98-1) 
147.99 1 41333 
rs7564121 rs12694477 
1 (0.98-1) 
147.99 1 41816 
rs13393102 rs10187756 
1 (0.98-1) 
148.02 1 3876 
rs13393102 rs13006868 
1 (0.98-1) 
148.02 1 6773 
rs13393102 rs7595290 1 (0.97-1) 144.17 0.977 10425 
rs13393102 rs28479291 
1 (0.98-1) 
148.02 1 13617 
rs13393102 rs12694475 
1 (0.98-1) 
148.02 1 14232 
rs13393102 rs10165222 
1 (0.98-1) 
148.02 1 21820 
rs13393102 rs13386094 
1 (0.98-1) 
148.02 1 22265 
rs13393102 rs13395224 
1 (0.98-1) 
147.99 1 40516 
rs13393102 rs12694477 
1 (0.98-1) 
147.99 1 40999 
rs10187756 rs13006868 
1 (0.98-1) 
148.02 1 2897 
rs10187756 rs7595290 1 (0.97-1) 144.17 0.977 6549 
rs10187756 rs28479291 
1 (0.98-1) 
148.02 1 9741 
rs10187756 rs12694475 
1 (0.98-1) 
148.02 1 10356 
rs10187756 rs10165222 
1 (0.98-1) 
148.02 1 17944 
rs10187756 rs13386094 
1 (0.98-1) 
148.02 1 18389 
rs10187756 rs13395224 
1 (0.98-1) 
147.99 1 36640 
rs10187756 rs12694477 
1 (0.98-1) 
147.99 1 37123 
rs13006868 rs7595290 1 (0.97-1) 144.17 0.977 3652 
rs13006868 rs28479291 
1 (0.98-1) 
148.02 1 6844 
rs13006868 rs12694475 
1 (0.98-1) 
148.02 1 7459 
rs13006868 rs10165222 
1 (0.98-1) 
148.02 1 15047 
rs13006868 rs13386094 
1 (0.98-1) 





147.99 1 33743 
rs13006868 rs12694477 
1 (0.98-1) 
147.99 1 34226 
rs7595290 rs28479291 
1 (0.97-1) 
144.17 0.977 3192 
rs7595290 rs12694475 
1 (0.97-1) 
144.17 0.977 3807 
rs7595290 rs10165222 
1 (0.97-1) 
144.17 0.977 11395 
rs7595290 rs13386094 
1 (0.97-1) 
144.17 0.977 11840 
rs7595290 rs13395224 
1 (0.97-1) 
144.13 0.977 30091 
rs7595290 rs12694477 
1 (0.97-1) 
144.13 0.977 30574 
rs28479291 rs12694475 
1 (0.97-1) 
148.02 1 615 
rs28479291 rs10165222 
1 (0.98-1) 
148.02 1 8203 
rs28479291 rs13386094 
1 (0.98-1) 
148.02 1 8648 
rs28479291 rs13395224 
1 (0.98-1) 
147.99 1 26899 
rs28479291 rs12694477 
1 (0.98-1) 
147.99 1 27382 
rs12694475 rs10165222 
1 (0.98-1) 
148.02 1 7588 
rs12694475 rs13386094 
1 (0.98-1) 
148.02 1 8033 
rs12694475 rs13395224 
1 (0.98-1) 
147.99 1 26284 
rs12694475 rs12694477 
1 (0.98-1) 
147.99 1 26767 
rs10165222 rs13386094 
1 (0.98-1) 
148.02 1 445 
rs10165222 rs13395224 
1 (0.98-1) 
147.99 1 18696 
rs10165222 rs12694477 
1 (0.98-1) 
147.99 1 19179 
rs13386094 rs13395224 
1 (0.98-1) 
147.99 1 18251 
rs13386094 rs12694477 
1 (0.98-1) 
147.99 1 18734 
rs13395224 rs12694477 
1 (0.98-1) 
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자궁 경부 부위의 인유두종바이러스 감염 상태와 관련된  
유전적 영향 및 감수성 유전자 좌 분석 
 
 
서울대학교 보건대학원  
보건학과 유전체역학전공  
정다은  
 
배경: 자궁경부암은 일부 아프리카와 아시아 지역의 여성에게서 첫 번째
로, 전세계적으로는 여성들에서 세 번째로 흔하게 발병하는 암이다. 인
유두종바이러스 감염은 자궁경부 상처와 암 발병의 주된 원인이며 자궁
경부암으로의 진행에 중요한 원인으로 작용한다. 그리고 여성들에서 인
유두종바이러스 감염 자체에 대한 전 세계적인 질병부담도 매우 크다. 
2012년에는 전 세계적으로 매년 610,000명의 새로운 환자가 발생하며 
863명의 20-74세 성인 여성에서 인유두종바이러스 감염의 유병률이 
10.4%임이 보고된 바 있다. 인유두종바이러스 감염은 유전이 될 것이라
는 가정이 있는데 그 이유는 인유두종바이러스 감염 후의 진행 양상이 
숙주의 유전적인 감수성과 환경요인에 따라 다르게 나타나기 때문이다. 
대부분 감염 후 자연적으로 치유가 되지만, 10-20%는 감염이 오랫동안 
지속이 되다가 cervical intraepithelial neoplasm (CINs)이 된다. CINs의 
30-40%는 invasive cancer of the cervix (ICC) 으로 진행된다.  
 
목적: 본 연구의 목적은 한국인 여성에서 인유두종바이러스 감염 상태에 
대한 유적적 영향이 존재한다는 사실을 확인하고, 그러한 사실을 근거로 
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이분화된 trait를 분석하는 여러 방법 중 현재까지 가장 최신의, 최근의 
방법을 이용하여 유전적 감수성 좌를 파악하는데 있다.  
 
방법: Healthy Twin Study에서 25-79세 910명의 여성 연구 참여자가 
모집되었다. univariate logistic regression analysis를 이용하여 인유두
종바이러스에 감염된 숙주의 유병률과 잠재 위험 요인에 따른 감염 상태
의 오즈비를 구하였다. 유전적 영향이 있는지를 평가하기 위해 ICC와 
SOLAR가 사용되었고 유전적 감수성 좌를 분석하기 위해 GWAF가 사용
되었다.  
 
결론: 여러 역학적 요인들 중에서 경구피임약만 인유두종바이러스 감염 
상태와 유의미한 연관이 있었고 본 연구에서 수행한 모든 분석에서 나이
와 경구피임약 복용 유무가 보정이 되었다. 일란성 쌍둥이쌍의 ICC 값은 
엄마-자녀과 이란성 쌍둥이쌍을 포함한 형제-자매 쌍의 값보다 높았다. 
또한, AE model에서 0.34 수준으로 유의미한 유전적 영향이 있음을 확
인하였다. 이러한 사실을 근거로 수행한 유전적 감수성 좌에 대한 전장 
유전체 연관성 분석에서는 additive model과 general model 각각에서 
인유두종바이러스 감염 여부와 가장 높은 유의성을 보인 단일 염기 다형성은 
rs13393102 와 rs7595290으로 나타났다. 이들의 유의 수준은 각각 
5.4E-7 과 8.0E-8 의 값을 보였고, 분석 후 다양한 visualization 방
법을 사용하여 해석을 하였다.  
 
논의: 한국인 여성에서의 인유두종바이러스 감염 상태에 대한 유전적 영
향은 많이 높지는 않았지만 유의미한 수준에 있었다. 결과를 통해 나타
난 유전자자들과 관련된 질병이나 기능들 중, additive model에서는 
BROX, CNTN5, GRM8, HMCN1, NEB, PDE4B, PRKAG2, PTPRJ, RHEB, 
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STRC, VNN1, ZBTB7C, ZC3H15, ZNF680, DPP6, RAD51B and WWOX 
이 endometrial cancer, uterine tumor 와 같은 질병과 ovarian cancer 
cell lines의 결합 기능에서 통계적으로 유의미한 연관성을 보였다. 또한, 
general model에서는 ADAM12, CNTN4, DPP6, GRM8, LRP1B, OBSCN, 
PDE4D, PLEKHH2, PRKAG2, PTPRJ, RHEB, STRC, STXBP6, VNN1, 
ZBTB7C, ZC3H15, ZNF680, PDE4D, WWOX, LEPR 그리고 DTD1 이 
endometrial cancer, uterine tumor 질병 그리고 자궁경부암 cell line의
G1/S 기 전이, 초기 혹은 진행된 수준의 endometriosis, ovarian 
cancer cell lines의 결합 기능 그리고 endometrial cancer cell line의 
세포자살과 같은 기능과 유의미한 연관성을 보였다.  
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